Repligen Corp. diskutieren
Repligen Corp.
WKN: 870980 / Symbol: RGEN / Name: Repligen Corp / Aktie / Pharmazeutika / Mid Cap /
112,00 €
-0,70 %
Repligen (RGEN) had its price target lowered by Wells Fargo & Company from $190.00 to $180.00. They now have an "overweight" rating on the stock.
Ratings data for RGEN provided by MarketBeat
Repligen (RGEN) had its price target lowered by Barclays PLC from $200.00 to $175.00. They now have an "overweight" rating on the stock.
Ratings data for RGEN provided by MarketBeat
Repligen (RGEN) had its price target lowered by UBS Group AG from $200.00 to $195.00. They now have a "buy" rating on the stock.
Ratings data for RGEN provided by MarketBeat
Neueste Beiträge
Barrington_Research in Merit Medical Systems diskutieren